Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (vol 10, pg 145, 2004)

被引：22

作者：

Willett, CG

Boucher, Y

di Tomaso, E

Duda, DG

Munn, LL

Tong, RT

Chung, DC

Sahani, DV

Kalva, SP

Kozin, SV

Mino, M

Cohen, KS

Scadden, DT

Hartford, AC

Fischman, AJ

Clark, JW

Ryan, DP

Zhu, AX

Blaszkowsky, LS

Chen, HX

Shellito, PC

Lauwers, GY

Jain, RK

机构：

来源：

关键词：

D O I：

10.1038/nm0604-649c

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Nat. Med. 10, 145–147 (2004). The complete trial schema was omitted from the article. The protocol is outlined below. Table 1.

引用

页码：649 / 649

页数：1